Skip to main content
Top
Published in: Medical Oncology 5/2024

01-05-2024 | Osteosarcoma | Original Paper

Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing

Authors: Kai Xiong, Yuqi Fang, Boyuan Qiu, Chaotao Chen, Nanchang Huang, Feiyuan Liang, Chuangming Huang, Tiantian Lu, Li Zheng, Jinmin Zhao, Bo Zhu

Published in: Medical Oncology | Issue 5/2024

Login to get access

Abstract

Osteosarcoma (OS) stands as the most prevalent primary bone cancer in children and adolescents, and its limited treatment options often result in unsatisfactory outcomes, particularly for metastatic cases. The tumor microenvironment (TME) has been recognized as a crucial determinant in OS progression. However, the intercellular dynamics between high TP53-expressing OS cells and neighboring cell types within the TME are yet to be thoroughly understood. In our study, we harnessed the single-cell RNA sequencing (scRNA-seq) technology in combination with the computational tool–Cellchat, aiming to elucidate the intercellular communication networks present within OS. Through meticulous quantitative inference and subsequent analysis of these networks, we succeeded in identifying significant signaling pathways connecting high TP53-expressing OS cells with proximate cell types, namely Macrophages, Monocytes, Endothelial Cells, and PVLs. This research brings forth a nuanced understanding of the intricate patterns and coordination involved in the TME’s intercellular communication signals. These findings not only provide profound insights into the molecular mechanisms underpinning OS but also indicate potential therapeutic targets that could revolutionize treatment strategies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125(1):229–34.PubMedPubMedCentralCrossRef Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125(1):229–34.PubMedPubMedCentralCrossRef
3.
go back to reference Casali PG, et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2018;29(Suppl 4):iv79–95.CrossRef Casali PG, et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2018;29(Suppl 4):iv79–95.CrossRef
7.
go back to reference Zhou Y, et al. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. Nat Commun. 2020;11(1):6322.PubMedPubMedCentralCrossRef Zhou Y, et al. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. Nat Commun. 2020;11(1):6322.PubMedPubMedCentralCrossRef
8.
go back to reference Yu L, Hongyu S, Yuxi C. Integration of single-cell sequencing and bulk expression data reveals chemokine signaling pathway in proliferating cells is associated with the survival outcome of osteosarcoma. BMC Med Genomics. 2023;16(1):180.PubMedPubMedCentralCrossRef Yu L, Hongyu S, Yuxi C. Integration of single-cell sequencing and bulk expression data reveals chemokine signaling pathway in proliferating cells is associated with the survival outcome of osteosarcoma. BMC Med Genomics. 2023;16(1):180.PubMedPubMedCentralCrossRef
9.
go back to reference Gao T, et al. Haplotype-aware analysis of somatic copy number variations from single-cell transcriptomes. Nat Biotechnol. 2023;41(3):417–26.PubMedCrossRef Gao T, et al. Haplotype-aware analysis of somatic copy number variations from single-cell transcriptomes. Nat Biotechnol. 2023;41(3):417–26.PubMedCrossRef
10.
go back to reference Wilk AJ, et al. Comparative analysis of cell-cell communication at single-cell resolution. Nat Biotechnol. 2023. Wilk AJ, et al. Comparative analysis of cell-cell communication at single-cell resolution. Nat Biotechnol. 2023.
14.
go back to reference Duffy MJ, et al. Targeting p53 for the treatment of cancer. Semin Cancer Biology. 2022;79:58–67.CrossRef Duffy MJ, et al. Targeting p53 for the treatment of cancer. Semin Cancer Biology. 2022;79:58–67.CrossRef
15.
go back to reference Wang X, Sun Q. TP53 mutations, expression and interaction networks in human cancers. Oncotarget. 2017;8(1):624.PubMedCrossRef Wang X, Sun Q. TP53 mutations, expression and interaction networks in human cancers. Oncotarget. 2017;8(1):624.PubMedCrossRef
16.
17.
go back to reference Cai D, et al. Prognostic value of p16, p53, and pcna in sarcoma and an evaluation of immune infiltration. J Orthop Surg Res. 2022;17(1):1–14.CrossRef Cai D, et al. Prognostic value of p16, p53, and pcna in sarcoma and an evaluation of immune infiltration. J Orthop Surg Res. 2022;17(1):1–14.CrossRef
18.
go back to reference Wu X, et al. Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients. Cancer Epidemiol. 2012;36(2):212–6.PubMedCrossRef Wu X, et al. Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients. Cancer Epidemiol. 2012;36(2):212–6.PubMedCrossRef
19.
go back to reference Blagih J, Buck MD, Vousden KH. p53, cancer and the immune response. J Cell Sci. 2020;133(5):jcs237453.PubMedCrossRef Blagih J, Buck MD, Vousden KH. p53, cancer and the immune response. J Cell Sci. 2020;133(5):jcs237453.PubMedCrossRef
23.
go back to reference Han D, et al. High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy. J Immunother Cancer. 2023 11(11). Han D, et al. High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy. J Immunother Cancer. 2023 11(11).
25.
go back to reference Liu Z, Sun D, Wang C. Evaluation of cell-cell interaction methods by integrating single-cell RNA sequencing data with spatial information. Genome Biol. 2022;23(1):1–38.CrossRef Liu Z, Sun D, Wang C. Evaluation of cell-cell interaction methods by integrating single-cell RNA sequencing data with spatial information. Genome Biol. 2022;23(1):1–38.CrossRef
26.
go back to reference Papadimitriou E, et al. On the role of pleiotrophin and its receptors in development and angiogenesis. Int J Dev Biol. 2022;66(12-3-):115–24.PubMedCrossRef Papadimitriou E, et al. On the role of pleiotrophin and its receptors in development and angiogenesis. Int J Dev Biol. 2022;66(12-3-):115–24.PubMedCrossRef
27.
go back to reference Knudsen AM, et al. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors. Neuro Oncol. 2022;24(7):1074–87.PubMedCrossRef Knudsen AM, et al. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors. Neuro Oncol. 2022;24(7):1074–87.PubMedCrossRef
28.
go back to reference Wei X, et al. Tumor-associated macrophages increase the proportion of cancer stem cells in lymphoma by secreting pleiotrophin. Am J Trans Res. 2019;11(10):6393. Wei X, et al. Tumor-associated macrophages increase the proportion of cancer stem cells in lymphoma by secreting pleiotrophin. Am J Trans Res. 2019;11(10):6393.
29.
go back to reference Himburg HA, et al. Chronic myeloid leukemia stem cells require cell-autonomous pleiotrophin signaling. J Clin Investig. 2020;130(1):315–28.PubMedCrossRef Himburg HA, et al. Chronic myeloid leukemia stem cells require cell-autonomous pleiotrophin signaling. J Clin Investig. 2020;130(1):315–28.PubMedCrossRef
30.
go back to reference Mikelis C, Koutsioumpa M, Papadimitriou E. Pleiotrophin as a possible new target for angiogenesis-related diseases and cancer. Recent Pat Anti-Cancer Drug Discov. 2007;2(2):175–86.CrossRef Mikelis C, Koutsioumpa M, Papadimitriou E. Pleiotrophin as a possible new target for angiogenesis-related diseases and cancer. Recent Pat Anti-Cancer Drug Discov. 2007;2(2):175–86.CrossRef
31.
32.
go back to reference Filippou PS, Karagiannis GS, Constantinidou A. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene. 2020;39(10):2040–54.PubMedCrossRef Filippou PS, Karagiannis GS, Constantinidou A. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene. 2020;39(10):2040–54.PubMedCrossRef
33.
go back to reference Tang Y, Kwiatkowski DJ, Henske EP. Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment. Nat Commun. 2022;13(1):5018.PubMedPubMedCentralCrossRef Tang Y, Kwiatkowski DJ, Henske EP. Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment. Nat Commun. 2022;13(1):5018.PubMedPubMedCentralCrossRef
34.
go back to reference Yu X, et al. MDK induces temozolomide resistance in glioblastoma by promoting cancer stem-like properties. Am J Cancer Res. 2022;12(10):4825.PubMedPubMedCentral Yu X, et al. MDK induces temozolomide resistance in glioblastoma by promoting cancer stem-like properties. Am J Cancer Res. 2022;12(10):4825.PubMedPubMedCentral
35.
36.
go back to reference Hu R, et al. Increased drug efflux along with midkine gene high expression in childhood B-lineage acute lymphoblastic leukemia cells. Int J Hematol. 2010;92(1):105–10.PubMedCrossRef Hu R, et al. Increased drug efflux along with midkine gene high expression in childhood B-lineage acute lymphoblastic leukemia cells. Int J Hematol. 2010;92(1):105–10.PubMedCrossRef
37.
go back to reference Kang HC, et al. Regulation of MDK expression in human cancer cells modulates sensitivities to various anticancer drugs: MDK overexpression confers to a multi-drug resistance. Cancer Lett. 2007;247(1):40–7.PubMedCrossRef Kang HC, et al. Regulation of MDK expression in human cancer cells modulates sensitivities to various anticancer drugs: MDK overexpression confers to a multi-drug resistance. Cancer Lett. 2007;247(1):40–7.PubMedCrossRef
38.
go back to reference Jia W, et al. New perspectives of physiological and pathological functions of nucleolin (NCL). Life Sci. 2017;186:1–10.PubMedCrossRef Jia W, et al. New perspectives of physiological and pathological functions of nucleolin (NCL). Life Sci. 2017;186:1–10.PubMedCrossRef
39.
go back to reference Zhang Y, et al. DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer. Cancer Lett. 2023;568:216288.PubMedCrossRef Zhang Y, et al. DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer. Cancer Lett. 2023;568:216288.PubMedCrossRef
40.
go back to reference Nomura I, et al. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol. 2003;112(6):1195–202.PubMedCrossRef Nomura I, et al. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol. 2003;112(6):1195–202.PubMedCrossRef
41.
go back to reference Lange T, et al. Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells. Carbohydr Res. 2014;389:39–45.PubMedCrossRef Lange T, et al. Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells. Carbohydr Res. 2014;389:39–45.PubMedCrossRef
43.
go back to reference Bao Y, et al. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer. Cell Mol Biol Lett. 2019;24:1–20.CrossRef Bao Y, et al. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer. Cell Mol Biol Lett. 2019;24:1–20.CrossRef
44.
go back to reference Mandoj C, et al. Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting. J Trans Med. 2018;16(1):1–9.CrossRef Mandoj C, et al. Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting. J Trans Med. 2018;16(1):1–9.CrossRef
45.
go back to reference Gong Z, et al. Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer. Aging. 2023;15(18):9479.PubMedPubMedCentralCrossRef Gong Z, et al. Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer. Aging. 2023;15(18):9479.PubMedPubMedCentralCrossRef
46.
go back to reference Machackova T, et al. MiR-215–5p reduces liver metastasis in an experimental model of colorectal cancer through regulation of ECM-receptor interactions and focal adhesion. Cancers. 2020;12(12):3518.PubMedPubMedCentralCrossRef Machackova T, et al. MiR-215–5p reduces liver metastasis in an experimental model of colorectal cancer through regulation of ECM-receptor interactions and focal adhesion. Cancers. 2020;12(12):3518.PubMedPubMedCentralCrossRef
47.
go back to reference Lo HC, et al. GMI, a Ganoderma microsporum protein, abolishes focal adhesion network to reduce cell migration and metastasis of lung cancer. Life Sci. 2023;335:122255.PubMedCrossRef Lo HC, et al. GMI, a Ganoderma microsporum protein, abolishes focal adhesion network to reduce cell migration and metastasis of lung cancer. Life Sci. 2023;335:122255.PubMedCrossRef
48.
Metadata
Title
Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing
Authors
Kai Xiong
Yuqi Fang
Boyuan Qiu
Chaotao Chen
Nanchang Huang
Feiyuan Liang
Chuangming Huang
Tiantian Lu
Li Zheng
Jinmin Zhao
Bo Zhu
Publication date
01-05-2024
Publisher
Springer US
Published in
Medical Oncology / Issue 5/2024
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-024-02318-4

Other articles of this Issue 5/2024

Medical Oncology 5/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine